Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5184535 | 0.93 | ALDH1A1 (0.34) | ALDH1A1MEN1KMT2A | |
| SCHEMBL5186166 | 0.92 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2A | |
| SCHEMBL16708446 | 0.87 | ALDH1A1 (0.39) | ALDH1A1MEN1KMT2A | |
| SCHEMBL4855432 | 0.84 | ALDH1A1 (0.33) | ALDH1A1MEN1KMT2A | |
| SCHEMBL16708430 | 0.80 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2A | |
| SCHEMBL16708431 | 0.80 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2A | |
| SCHEMBL4865300 | 0.80 | SCN9A (0.33) | ALDH1A1MEN1KMT2A | |
| SCHEMBL4105503 | 0.79 | ALDH1A1 (0.37) | ALDH1A1MEN1KMT2A | |
| SCHEMBL4110153 | 0.79 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2A | |
| SCHEMBL4863587 | 0.78 | ALDH1A1 (0.32) | ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7456311-B2 | Adamantane derivative, process for producing the same, and photosensitive material for photoresist | IDEMITSU KOSAN CO., LTD. (JP) | 2008-11-25 | — | — | US | disclosed |
| US-20080009647-A1 | Adamantane Derivative, Process for Producing the Same, and Photosensitive Material for Photoresist | IDEMITSU KOSAN CO., LTD. (JP) | 2008-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009647-A1 | Adamantane Derivative, Process for Producing the Same, and Photosensitive Material for Photoresist | LSS, C1S, DHPS | ALDH1A1 1544/4885MEN1 1643/4885KMT2A 2612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.